Search

A recent report from Northwestern University discusses the role of oxidative stress in the development and maintenance of atrial fibrillation (AF), the most common sustained arrhythmia in clinical practice. The research highlights the need for improved therapeutic strategies targeting oxidative stress to prevent or treat AF. Funded by the American Heart Association and the National Institutes of Health, this peer-reviewed study provides insights into the complex biology of AF and the potential for targeted interventions. For more information, the full article can be accessed in the Journal of Molecular and Cellular Cardiology. [Extracted from the article]

Researchers from Northwestern University have conducted a study on the management of cardiac arrhythmias during pregnancy, highlighting the increasing incidence of arrhythmias among pregnant individuals. The study focuses on common arrhythmias, risk factors, diagnosis, and management strategies, as well as recommendations for peripartum monitoring and labor analgesia. Additionally, the research reviews the management of cardioversion, pacemakers, implantable cardioverter-defibrillators, and advanced cardiac life support in the context of pregnancy. This peer-reviewed study provides valuable insights for anesthesiologists caring for obstetric patients. [Extracted from the article]

A study conducted at Stanford University examined the prognostic value of atrial fibrillation (AF) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). The study found that AF was an independent prognostic factor for all-cause mortality in patients with ATTR-CM. However, the presence of AF did not impact the efficacy of tafamidis treatment in these patients. This research provides valuable insights into the relationship between AF and mortality in patients with ATTR-CM. [Extracted from the article]

A recent study conducted at Cedars Sinai Medical Center in Los Angeles, California, explored the role of autonomic nerve activity in paroxysmal atrial fibrillation (PAF) and premature atrial contraction (PAC) clusters. The researchers found that a single burst of skin sympathetic nerve activity (SKNA) can toggle on and off PAF and PAC episodes. The duration of these episodes was typically less than 10 minutes, and there were significant circadian variations in all types of PAF. The study suggests that the absence of continued SKNA after the onset may affect the maintenance of these arrhythmias. [Extracted from the article]

A recent study conducted by Northwell Health in Mt. Kisco, New York, examined the optimal duration of electrocardiographic monitoring to assess the burden of premature ventricular contractions (PVCs) and understand the clinical characteristics associated with frequent PVCs and nonsustained ventricular tachycardia. The study analyzed commercial data from June 2011 to April 2022 and found that extending ambulatory monitoring beyond 24 hours to 7 days or more improved the accuracy of assessing PVC burden. The research concluded that ventricular tachycardia frequency and duration vary based on the initial PVC density, highlighting the need for prolonged cardiac monitoring. [Extracted from the article]

A recent study conducted by researchers from McMaster University in Hamilton, Canada, explores the potential of Factor XI (FXI) inhibitors as next-generation anticoagulants for the treatment of cardiovascular diseases, specifically atrial fibrillation. The researchers suggest that FXI inhibitors may offer effective anticoagulation with reduced bleeding risks compared to current therapies. Ongoing phase III trials are being conducted to further investigate the efficacy of FXI inhibitors in stroke, acute coronary syndrome, and atrial fibrillation. However, more research is needed to establish the role of FXI inhibitors in clinical practice and address remaining questions. [Extracted from the article]

A study conducted at the Mayo Clinic in Rochester, Minnesota aimed to investigate the effects of genetic variants on atrial myopathy, atrial fibrillation (AF) clinical course, and catheter ablation outcomes in patients with hypertrophic cardiomyopathy (HCM). The study found that patients with MYBPC3- or MYH7-mediated HCM had more low-amplitude left atrial signals, suggesting fibrosis. However, catheter ablation was still found to be an effective rhythm-control strategy for these patients. The study provides valuable insights into the atrial substrate of patients with HCM and its impact on AF treatment outcomes. [Extracted from the article]

A study conducted at Mount Sinai Medical Center in Miami Beach, Florida, examined the use of intravenous diltiazem infusions for patients with atrial fibrillation (AF) or atrial flutter (AFL) in the emergency department (ED). The researchers compared the outcomes of patients who received a diltiazem drip after an IV diltiazem bolus to those who did not receive a drip. The study found that the use of a diltiazem drip was associated with less rate control in the ED and longer hospital stays. These findings suggest that alternative treatments may be more effective for rate control in patients with AF or AFL. [Extracted from the article]

A new report from McMaster University in Hamilton, Canada, presents findings on the effectiveness and safety of oral anticoagulation for stroke prevention in patients with device-detected atrial fibrillation. The researchers conducted a systematic review of randomized trials and identified two trials that evaluated the use of edoxaban and apixaban. The meta-analysis of these trials showed that oral anticoagulation with these agents reduced the risk of ischemic stroke and a composite of cardiovascular events, but increased the risk of major bleeding. The results provide high-quality evidence for the use of oral anticoagulation in this patient population. [Extracted from the article]

A new report from Baylor University College of Medicine discusses the association between neighborhood household income and clinical outcomes for patients admitted to the hospital for atrial fibrillation (AF). The study found that patients in higher-income neighborhoods had lower comorbidity burden, lower in-hospital mortality, shorter length of stay, higher procedure utilization, and higher healthcare costs compared to patients in lower-income neighborhoods. The research highlights the need for further investigation into the drivers of these disparities and strategies to improve healthcare disparities between socioeconomic groups. [Extracted from the article]

A recent study conducted at the Mayo Clinic in Rochester, Minnesota explores the relationship between atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF). The researchers suggest that individuals with either condition should be screened for the other, as this may help guide treatment decisions and reduce complications. Screening for occult HFpEF in AF patients may involve additional testing such as exercise right heart catheterization, while AF screening in HFpEF patients may identify cases where anticoagulation can reduce stroke risk. The study emphasizes the importance of screening in understanding the overlapping symptoms and guiding treatments for both conditions. [Extracted from the article]

A new report from Mt. Royal University in Calgary, Canada discusses an evidence-based approach for treating patients with paroxysmal atrial fibrillation (PAF) using class IC antiarrhythmic therapy. The study suggests that after successful trialing of pill-in-the-pocket (PIP) therapy in a monitored environment, nurse practitioners can prescribe oral medication to chemically cardiovert PAF into normal sinus rhythm in an unmonitored out-of-hospital setting. This method has been found to reduce emergency department visits and hospitalizations, making it an effective first-line treatment for PAF. The research has been peer-reviewed and published in The Journal for Nurse Practitioners. [Extracted from the article]

A recent study conducted by the Population Health Research Institute in Hamilton, Canada, examined the effectiveness of catheter ablation in treating atrial fibrillation (AF) in patients with heart failure. The study found that catheter ablation was associated with a reduced risk of heart failure events in patients with heart failure and reduced ejection fraction (HFrEF), but had limited or no benefit in patients with heart failure and preserved ejection fraction (HFpEF). The researchers suggest that further trials may provide more insight into the role of catheter ablation for AF in HFpEF. This information is important for individuals researching alternative treatments for atrial fibrillation and heart failure. [Extracted from the article]

A recent study conducted at the Royal Alexandra Hospital in Edmonton, Canada compared two approaches to resuscitation in infantile piglets with bradycardia-induced cardiac arrest. The study aimed to determine whether continuous chest compression with asynchronized ventilation (CCaV) or continuous chest compression superimposed with sustained inflation (CC + SI) was more effective in achieving return of spontaneous circulation (ROSC). The results showed that CC + SI reduced the time to ROSC compared to CCaV and required less epinephrine. The study concluded that CC + SI improves resuscitative efforts in infantile piglets by increasing intrathoracic pressure and minute ventilation. [Extracted from the article]

A study conducted by Auburn University examined the benefits and risks of initiating oral anticoagulants (OACs) in patients with atrial fibrillation (AFib) and cancer. The researchers analyzed data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and found that initiating OACs at a higher risk of stroke (CHA2DS2-VASc score >= 6) was more beneficial in preventing ischemic stroke and bleeding. However, in patients with advanced cancer or a low life expectancy, OAC initiation at any CHA2DS2-VASc level increased the risk of stroke and did not reduce the risk of bleeding. The study suggests that patients with cancer and AFib should consider their individual risk factors when deciding to initiate OACs. [Extracted from the article]

A study conducted at Ohio State University investigated the incidence of esophageal injury in patients undergoing ablation of atrial fibrillation (AF) with and without an esophageal deviating device. The study found that the use of an esophageal deviating device resulted in a significant reduction in ablation-related esophageal lesions without any adverse events. The research suggests that this novel deviating device, which uses vacuum suction and mechanical deflection, may be an effective tool in reducing complications during AF ablation procedures. [Extracted from the article]

A recent study conducted by the Department of Cardiac Electrophysiology in Pensacola, Florida aimed to determine if prophylactic use of colchicine could reduce the incidence and severity of pericarditis after radiofrequency ablation for atrial fibrillation (AF). The study involved 139 patients who were randomized to receive either no post-procedure prophylaxis or colchicine for 7 days. The primary outcome of clinical pericarditis was reached in 10.6% of patients in the standard of care group and 9.6% of patients in the colchicine group. However, the colchicine group experienced a higher incidence of gastrointestinal side effects. The study concluded that prophylactic colchicine therapy did not affect the incidence of post-ablation pericarditis. [Extracted from the article]

A recent study conducted at the Medical University of South Carolina examined the use of cardiac implantable electronic devices (CIEDs) in recipients of orthotopic heart transplants. The study found that the rate of CIED implantation after heart transplantation has decreased significantly with the development of new surgical techniques. The research also revealed that recipients who received CIEDs had a longer survival rate after transplantation. The study concluded that early sinus node dysfunction requiring permanent pacing is rare. [Extracted from the article]

A recent study conducted at the Hospital of the University of Pennsylvania has found that patients with arrhythmogenic right ventricular dysplasia (ARVC) are at risk of developing atrial arrhythmias (AAs) even after undergoing ventricular tachycardia (VT) ablation. The study analyzed data from 119 ARVC patients who underwent VT ablation and found that 34% of them developed AAs, including atrial fibrillation, atrial flutter, and atrial tachycardia. Ablation procedures were successful in preventing AAs in 78% of patients. The study also identified risk factors for developing typical atrial flutter in ARVC patients. This research provides valuable insights into the management of AAs in ARVC patients and highlights the importance of atrial ablation in controlling these arrhythmias. [Extracted from the article]

A study conducted at Arrowhead Regional Medical Center in Colton, California examined the effectiveness and safety of ibutilide in cardioversion of atrial fibrillation (AF) in medical and surgical intensive care patients. The study found that females had a higher conversion rate to normal sinus rhythm (NSR) compared to males, regardless of whether they were pretreated with magnesium sulfate. Additionally, pretreatment with magnesium sulfate followed by ibutilide was associated with increased conversion to NSR. The findings suggest potential gender differences in the effectiveness of ibutilide in treating AF. [Extracted from the article]

A new report from Brigham and Women's Hospital in Boston, Massachusetts presents fresh data on the use of direct oral anticoagulants (DOACs) for stroke prevention in atrial fibrillation. While DOACs are generally preferred over vitamin K antagonists, the report suggests that they may not be as effective or safe in certain conditions such as mechanical heart valves, thrombotic antiphospholipid syndrome, and atrial fibrillation associated with rheumatic heart disease. The report provides an evidence-based review of randomized controlled trials on DOACs, detailing their efficacy and safety, as well as areas where further research is needed. [Extracted from the article]

A recent study conducted by the University of Illinois compared the effectiveness of the WATCHMAN device and direct oral anticoagulants (DOAC) in preventing hemorrhagic strokes in patients with nonvalvular atrial fibrillation (AFib). The study found that the WATCHMAN device was comparable to DOAC therapy in preventing hemorrhagic strokes and may provide benefits in reducing bleeding events, transient ischemic attacks (TIAs), and ischemic strokes. The study involved a retrospective analysis of patients from 2010 to 2020 and consisted of 2248 patients in each cohort. The findings suggest that the WATCHMAN device could be a viable option for primary prevention in high-risk populations. [Extracted from the article]

A new report from Duke University School of Medicine in Durham, North Carolina, presents fresh data on tachycardia, a potentially fatal cardiac arrhythmia. The research focuses on junctional ectopic tachycardia (JET) and its connection to ryanodine type 2 receptor (RyR2)-mediated Ca2+ leak. The study found that a small molecule called EL20 can block this Ca2+ leak and rapidly convert JET to sinus rhythm in a mouse model. However, EL20 is quickly degraded in mouse and human plasma, limiting its potential as a therapy for JET. [Extracted from the article]

Researchers from the Minneapolis Heart Institute have conducted a study on the impact of atrial fibrillation on the outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). The study analyzed the baseline characteristics and procedural outcomes of 9,166 CTO PCIs performed at various centers between 2012 and 2023. The researchers found that patients with atrial fibrillation were older and had a higher incidence of comorbidities, longer procedure times, and more complex lesions. However, technical success and in-hospital major adverse cardiovascular events (MACE) were similar between patients with and without atrial fibrillation. The study concluded that although patients with atrial fibrillation had higher MACE and mortality during follow-up, these differences were not significant after adjusting for potential confounding variables. [Extracted from the article]

A recent study conducted by Weill Cornell Medicine in New York City aimed to determine whether anticoagulation or antiplatelet therapy is more effective for preventing recurrent stroke in patients with cryptogenic stroke and evidence of atrial cardiopathy but no atrial fibrillation. The study involved 1,015 participants and compared the use of apixaban (an anticoagulant) to aspirin (an antiplatelet agent). After a mean follow-up of 1.8 years, the trial was stopped due to futility, as apixaban did not significantly reduce the risk of recurrent stroke compared to aspirin. The study also found that apixaban had a lower risk of symptomatic intracranial hemorrhage compared to aspirin. [Extracted from the article]

A recent study conducted at the Lerner College of Medicine in Cleveland, Ohio, explored the relationship between Postural Orthostatic Tachycardia Syndrome (POTS) and comorbid anxiety. The study found that individuals with a diagnosis of an anxiety disorder had a higher incident rate of treatment changes for POTS management. This may be due to the underlying pathophysiology and treatment of anxiety disorders, as well as the challenges in differentiating symptoms. The researchers concluded that further research is needed to determine the best approach to care for POTS patients with comorbid anxiety. [Extracted from the article]

A new study conducted at University Hospital in Cleveland Heights, Ohio, has found that postoperative atrial fibrillation (POAF) is a common complication following lung lobectomy and is associated with increased risk of stroke, mortality, and prolonged hospital stay. The study aimed to identify the risk factors for POAF after lobectomy and found that the risk of both early and chronic POAF was higher in patients who underwent open lobectomy compared to those who underwent video-assisted thoracoscopic surgery (VATS). The researchers concluded that healthcare providers should inform patients about the risk of chronic arrhythmia after lung resection. [Extracted from the article]

A new study conducted by the Lankenau Institute for Medical Research in Wynnewood, Pennsylvania, explores the potential of using a combination of sodium channel block and mild elevation of extracellular potassium to effectively and safely cardiovert atrial fibrillation (AF). The study used a canine model and found that the combination approach was able to terminate AF and prevent its recurrence in the short term. The findings suggest that this novel approach could provide more effective and rapid cardioversion of AF. The research has been peer-reviewed and published in Heart Rhythm. [Extracted from the article]

A study conducted by researchers at the University of Washington explores the use of computational models to identify possible substrates for persistent atrial fibrillation (AF) ablation. The study focuses on the modulation of conduction velocity (W) in persistent AF models to improve simulation agreement with clinical arrhythmias. The researchers found that specific calibration of W values could improve model/clinical agreement and model usefulness, particularly in patients with higher body mass index or left atrial fibrosis burden. This research has the potential to facilitate better personalized modeling and has immediate clinical implications. [Extracted from the article]

A new report from the Cleveland Clinic provides insights into atrial fibrillation, a type of heart disorder. The research identifies a specific genetic variant, rs17171731, that is associated with an increased risk of atrial fibrillation. This variant regulates the expression of the FAM13B gene, and its decreased expression leads to pro-arrhythmogenic changes in sodium current and calcium handling. The study suggests that investigating FAM13B expression and its regulation could lead to the development of patient-specific therapeutics for atrial fibrillation. [Extracted from the article]

A new report from Cedars Sinai Medical Center in Los Angeles, California explores the role of the autonomic nervous system in atrial fibrillation (AF), a type of cardiac arrhythmia. The researchers suggest that reducing sympathetic tone through neuromodulation methods may be beneficial in controlling AF. The review discusses the relationship between the autonomic nervous system and AF, as well as various methods and mechanisms of neuromodulation. The researchers propose that noninvasive or minimally invasive neuromodulation techniques will be most useful in managing AF in the future. [Extracted from the article]

A new study conducted by researchers at the University of British Columbia in Vancouver, Canada, has found that catheter ablation using radiofrequency energy can reduce the progression of atrial fibrillation (AF) to persistent atrial tachyarrhythmia. The study enrolled 346 patients with drug-refractory paroxysmal AF and randomly assigned them to different ablation methods. The results showed that patients who underwent radiofrequency ablation had a lower incidence of persistent atrial tachyarrhythmia compared to those who underwent cryoballoon ablation. This research provides new insights into the treatment of AF and its progression. [Extracted from the article]

A new report discusses research findings on atrial fibrillation (AF), a type of heart disorder. The research suggests that the simultaneous activation of the sympathetic and parasympathetic nervous systems is important for the initiation of AF, but an imbalance in the sympathetic system is characteristic of autonomic remodeling in long-standing persistent AF. The study explores the link between cardiac autonomic and metabolic remodeling and the potential roles of different autonomic modulation strategies in managing AF. The research has been peer-reviewed and provides valuable insights into the understanding and treatment of AF. [Extracted from the article]

Researchers at Mayo Clinic have conducted a survey to investigate the perceptions and approaches of physicians regarding transcatheter left atrial appendage occlusion (LAAO) for stroke reduction in atrial fibrillation. The survey included a nationally representative sample of physicians from various specialties. The top reasons for considering LAAO were a history of intracranial bleeding, major extracranial bleeding, and gastrointestinal lesions, while the top reasons for withholding LAAO were other indications for long-term oral anticoagulation, low bleeding risk, and low stroke risk. The survey found no difference in physicians' decision-making based on patients' race, gender, or the concordance between patients' and physicians' race or gender. The findings of this survey provide valuable insights that can help customize future educational activities and establish evidence-based best practices for stroke prevention in atrial fibrillation. [Extracted from the article]

A new report from Weill Cornell Medicine discusses research findings on the association between intraoperative left atrial and left ventricular diastolic function and postoperative atrial fibrillation. The study found that baseline preoperative intraoperative left ventricular diastolic function is independently associated with a higher risk of postoperative atrial fibrillation after cardiac surgery. The research suggests that further studies are needed to determine if interventions aimed at optimizing intraoperative left ventricular diastolic function during cardiac surgery can reduce the risk of postoperative atrial fibrillation. [Extracted from the article]

A study conducted at the Cleveland Clinic Foundation in Ohio has found that a novel temperature-controlled catheter used in ablation procedures for paroxysmal atrial fibrillation (AF) is safe and effective. The study involved 191 participants, with 166 undergoing ablation with the new catheter. The results showed significant improvements in quality of life and a reduction in the use of antiarrhythmic drugs, cardioversion, and cardiovascular hospitalization. The researchers concluded that the use of the temperature-controlled catheter led to meaningful improvements in patient outcomes. [Extracted from the article]

A research report from Beth Israel Deaconess Medical Center in Boston, Massachusetts discusses the correlation between functional substrate mapping and cardiac computed tomography-derived wall thinning for ventricular tachycardia (VT) ablation. The study aimed to determine the relationship between myocardial wall thinning and VT substrate mapping using isochronal late activation mapping. The findings suggest that wall thinning may be useful for more efficient mapping in patients with infarct-related cardiomyopathies, but wall thickness channels are not sufficient for localizing wavefront discontinuities. This research has been peer-reviewed and published in JACC Clinical Electrophysiology. [Extracted from the article]

A recent report from the University of Toronto discusses the relationship between obstructive sleep apnea (OSA) and atrial fibrillation (AF). The research highlights that OSA is highly prevalent in patients with AF and plays a causal role in its pathogenesis. The presence of OSA in AF patients is associated with increased symptom burden and hospitalizations. The report also mentions that continuous positive airway pressure (CPAP) therapy may attenuate the risk of AF recurrence post ablation or cardioversion. However, further research is needed to guide management decisions regarding screening and treatment of OSA in AF populations. [Extracted from the article]

A report from Cleveland Clinic discusses the use of a novel technique called catheter-based electroporation for the ablation of cardiac arrhythmias. The current standard of care for invasive electrophysiology involves the use of thermal energy, but safety concerns remain. Catheter-based electroporation, also known as pulsed-field ablation, is a nonthermal ablation technique that applies high-voltage electrical fields to selectively ablate myocardial tissue while sparing neighboring structures. Ongoing studies are investigating the potential benefits of this technique compared to radiofrequency ablation. The research provides an overview of the current evidence from preclinical and clinical trials on catheter-based electroporation. [Extracted from the article]

A recent report discusses research conducted by the University of Western Ontario on the detection of atrial fibrillation (AF) in routine electroencephalogram (EEG) recordings. The researchers found that AF was detected in 0-0.2% per decade of life until age 60-69 years, with the prevalence increasing in older age groups. The study suggests that the ECG trace should be carefully analyzed for AF, especially in patients over 60 years of age, and any detected cases should be brought to the attention of the referring doctor. This research has been peer-reviewed and published in the Canadian Journal of Neurological Sciences. [Extracted from the article]

A new study conducted at the Cleveland Clinic in Ohio examined the safety, outcomes, and quality of life for elderly and very elderly patients undergoing catheter ablation for atrial fibrillation (AF). The study found that catheter ablation was safe and effective for these patients, with minimal major complications. However, the very elderly patients had a higher rate of AF recurrence compared to the elderly and non-elderly patients. Overall, catheter ablation resulted in a significant improvement in quality of life for all age groups. The study highlights the potential benefits of this procedure for elderly patients with AF. [Extracted from the article]

Toronto, Canada, North and Central America, Cardiac Arrhythmias, Cardiology, Cardiovascular, Health and Medicine, Heart Disease, Heart Disorders and Diseases, Tachycardia, Ventricular Tachycardia Keywords: Toronto; Canada; North and Central America; Cardiac Arrhythmias; Cardiology; Cardiovascular; Health and Medicine; Heart Disease; Heart Disorders and Diseases; Tachycardia; Ventricular Tachycardia EN Toronto Canada North and Central America Cardiac Arrhythmias Cardiology Cardiovascular Health and Medicine Heart Disease Heart Disorders and Diseases Tachycardia Ventricular Tachycardia 643 643 1 08/28/23 20230828 NES 230828 2023 AUG 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on Heart Disorders and Diseases - Ventricular Tachycardia. [Extracted from the article]

Quebec City, Canada, North and Central America, Atrial Fibrillation, Cardiac Arrhythmias, Drugs and Therapies, Health and Medicine, Heart Disease, Heart Disorders and Diseases Keywords: Quebec City; Canada; North and Central America; Atrial Fibrillation; Cardiac Arrhythmias; Drugs and Therapies; Health and Medicine; Heart Disease; Heart Disorders and Diseases EN Quebec City Canada North and Central America Atrial Fibrillation Cardiac Arrhythmias Drugs and Therapies Health and Medicine Heart Disease Heart Disorders and Diseases 763 763 1 07/31/23 20230731 NES 230731 2023 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on Heart Disorders and Diseases - Atrial Fibrillation. [Extracted from the article]

According to the news editors, the research concluded: "Electrical post-cardioversion recurrence in subjects with long-standing, persistent AF is associated with elevated levels of AngII and aldosterone." Keywords: Mexico City; Mexico; North and Central America; 11-Hydroxycorticosteroids; Adrenal Cortex Hormones; Aldosterone; Angiotensin II; Angiotensins; Atrial Fibrillation; Autacoids; Biological Factors; Biomarkers; Cardiac Arrhythmias; Diagnostics and Screening; Health and Medicine; Heart Disease; Heart Disorders and Diseases; Neuropeptides; Oligopeptides; Peptide Hormones; Peptide Proteins; Peptides; Proteins EN Mexico City Mexico North and Central America 11-Hydroxycorticosteroids Adrenal Cortex Hormones Aldosterone Angiotensin II Angiotensins Atrial Fibrillation Autacoids Biological Factors Biomarkers Cardiac Arrhythmias Diagnostics and Screening Health and Medicine Heart Disease Heart Disorders and Diseases Neuropeptides Oligopeptides Peptide Hormones Peptide Proteins Peptides Proteins 486 486 1 05/08/23 20230508 NES 230508 2023 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on Heart Disorders and Diseases - Atrial Fibrillation. [Extracted from the article]

Keywords: Toronto; Canada; North and Central America; Arrhythmia; Cardiac Arrhythmias; Cardiology; Health and Medicine; Heart Disorders and Diseases EN Toronto Canada North and Central America Arrhythmia Cardiac Arrhythmias Cardiology Health and Medicine Heart Disorders and Diseases 753 753 1 04/17/23 20230417 NES 230417 2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on Heart Disorders and Diseases - Cardiac Arrhythmias. For more information on this research see: A Polypyrrole-polycarbonate Polyurethane Elastomer Alleviates Cardiac Arrhythmias Via Improving Bio-conductivity. [Extracted from the article]

According to news reporting out of Hamilton, Canada, by NewsRx editors, the research stated, "Atrial fibrillation (AF) is a common cause of stroke. Keywords: Hamilton; Canada; North and Central America; Atrial Fibrillation; Cardiac Arrhythmias; Cerebrovascular Diseases and Conditions; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Health and Medicine; Heart Disease; Heart Disorders and Diseases; Risk and Prevention; Stroke EN Hamilton Canada North and Central America Atrial Fibrillation Cardiac Arrhythmias Cerebrovascular Diseases and Conditions Clinical Research Clinical Trials and Studies Drugs and Therapies Health and Medicine Heart Disease Heart Disorders and Diseases Risk and Prevention Stroke 380 380 1 04/17/23 20230417 NES 230417 2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Fresh data on Heart Disorders and Diseases - Atrial Fibrillation are presented in a new report. [Extracted from the article]